Serum and fecal biomarkers predict response to Infliximab therapy in pediatric patients with Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD) is a chronic, idiopathic autoimmune disease characterized by the inflammation of the GI tract. The main subcategories of IBD include Crohn Disease (CD), ulcerative colitis (UC), and Indeterminate Colitis (IC). Currently, IBD is diagnosed and evaluated using clinical,...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/41280 |